DOCSLIB.ORG

Cryptococcus Gattii Isolates Chapter 7

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Cryptococcus Gattii Isolates Chapter 7 PDF hosted at the Radboud Repository of the Radboud University Nijmegen The following full text is a publisher's version. For additional information about this publication click this link. http://hdl.handle.net/2066/128930 Please be advised that this information was generated on 2021-10-10 and may be subject to change. Cryptococcus neoformans Cryptococcus complex: molecular, clinical and clinical molecular, complex: Cryptococcus neoformans complex: molecular, clinical and in vitro studies in vitro studies M.T. Illnait Zaragozí 2014 Zaragozí Illnait M.T. studies María Teresa Illnait Zaragozí Cryptococcus neoformans complex: molecular, clinical and in vitro studies ISBN: 978-94-6203-627-7 Printed by CPI Wöhrmann Print Service, Zutphen, The Netherlands. Layout by Ferry Hagen. Copyright © 2014 by Maria Teresa Illnait Zaragozí, All rights reserved. No part of this thesis may be reproduced or transmitted in any form or by any means without written permission of the author. The work described in this thesis was performed in several periods from 2007-2012 at the Canisius-Wilhelmina Hospital, Nijmegen, The Netherlands Cover: Front: Almond tree, Havana, Cuba Back: Mango tree and pigeon, Havana, Cuba Pictures: María Teresa Illnait Zaragozí Cryptococcus neoformans complex: molecular, clinical and in vitro studies Proefschrift ter verkrijging van de graad van doctor aan de Radboud Universiteit Nijmegen op gezag van de rector magnificus prof. mr. S.C.J.J. Kortmann, volgens besluit van het college van decanen in het openbaar te verdedigen op woensdag 27 augustus 2014 om 10.30 uur precies door María Teresa Illnait Zaragozí geboren op 10 maart 1967 te Havana, Cuba Promotoren Prof. dr. A. Voss Prof. dr. P.E. Verweij Copromotoren Dr. J.F.G.M. Meis (Canisius-Wilhelmina Ziekenhuis, Nijmegen) Dr. F. Hagen (Canisius-Wilhelmina Ziekenhuis, Nijmegen) Manuscriptcommissie Prof. dr. M.G. Netea Prof. dr. B.E. de Pauw Prof. dr. G.S. de Hoog (CBS-KNAW Fungal Biodiversity Centre, Utrecht) Paranimfen Dr. Ph.A. Van Damme N. Manraad Cryptococcus neoformans complex: molecular, clinical and in vitro studies Doctoral Thesis to obtain the degree of doctor from Radboud University Nijmegen on the authority of the Rector Magnificus prof. dr. S.C.J.J. Kortmann, according to the decision of the Council of Deans to be defended in public on Wednesday, August 27, 2014 at 10.30 AM by María Teresa Illnait Zaragozí Born on March 10, 1967 in Havana, Cuba Supervisors Prof. dr. A. Voss Prof. dr. P.E. Verweij Co-supervisors Dr. J.F.G.M. Meis (Canisius-Wilhelmina Ziekenhuis, Nijmegen) Dr. F. Hagen (Canisius-Wilhelmina Ziekenhuis, Nijmegen) Doctoral Thesis Committee Prof. dr. M.G. Netea Prof. dr. B.E. de Pauw Prof. dr. G.S. de Hoog (CBS-KNAW Fungal Biodiversity Centre, Utrecht) Paranymphs Dr. Ph.A. Van Damme N. Manraad Sometimes we feel that what we do is just a drop in the sea, but the ocean would be less without a drop. Mother Teresa of Kolkata Table of contents Chapter 1. General Introduction 11 Part I Molecular characterization of clinical and environmental C. neoformans species complex isolated from Cuba and The Netherlands Chapter 2. Microsatellite typing of clinical and environmental 35 Cryptococcus neoformans var. grubii isolates from Cuba shows multiple genetic lineages Chapter 3. Extensive genetic diversity within the Dutch clinical 43 Cryptococcus neoformans population Chapter 4. Microsatellite typing and susceptibilities of serial 53 Cryptococcus neoformans isolates from Cuban patients with recurrent cryptococcal meningitis Part II Antifungal susceptibility of Cuban and worldwide cryptococcal strains Chapter 5. In vitro activity of the new azole isavuconazole (BAL 61 4815) compared with six other antifungal agents against 162 Cryptococcus neoformans isolates from Cuba Chapter 6. In vitro antifungal susceptibilities and amplified 65 fragment length polymorphism genotyping of a worldwide collection of 350 clinical, veterinary, and environmental Cryptococcus gattii isolates Chapter 7. Cryptococcus neoformans - Cryptococcus gattii 73 species complex: an international study of wild- type susceptibility endpoint distributions and epidemiological cutoff values for fluconazole, itraconazole, posaconazole, and voriconazole Part III Clinical and environmental studies Chapter 8. Environmental isolation and characterization of 83 Cryptococcus species from living trees in Havana city, Cuba Chapter 9. Reactivation of a Cryptococcus gattii infection in a 91 cheetah (Acinonyx jubatus) held in the National Zoo, Havana, Cuba Chapter 10. Fatal Cryptococcus gattii genotype AFLP5 infection in 97 an immunocompetent Cuban patient Chapter 11. Cryptococcus gattii induces a cytokine pattern that is 103 distinct from other cryptococcal species Chapter 12. General discussion and future perspectives 115 Chapter 13. Summary - Samenvatting - Resumen 133 Chapter 14. Acknowledgments 145 Curriculum vitae List of publications Chapter General Introduction 1 Chapter 1 The incidence of cryptococcosis, initially considered unusual, began to increase with the arrival of acquired immunodeficiency syndrome (AIDS) in the 1980s to become one of the most important mycoses worldwide. After the advent of highly effective antiretroviral therapy in the mid-1990, its frequency started to decline in developed countries. However, cryptococcal meningitis remained the most common life- threatening opportunistic fungal infection with an estimated annual mortality of 625,000 persons, which ranks cryptococcosis as fourth among the most common causes of death due to infections in sub-Saharan Africa, higher than tuberculosis. (Armstrong et al. 2014; Park et al., 2009; La Hoz and Papas, 2013). Additionally, it has been reported that up to 6% of people with impaired cellular immunity due to other causes, are at risk of developing clinically apparent infections due to Cryptococcus (Bratton et al., 2012). From discovery of the causative agent of cryptococcosis to its current taxonomy Probably the first case of cryptococcosis was descrited in 1861 by Zenker. However because of the lack of microbiological evidence, the first case description is usually attributed to doctors Otto Busse and Abraham Buschke from Germany. In 1894 they reported the isolation of a microorganism from an injury in a 31-year-old woman and named it Saccharomyces hominis. Almost simultaneously, Sanfelice described the presence of encapsulated yeasts obtained from fermented peach juice; he demonstrated its pathogenicity in laboratory animals and called it Saccharomyces neoformans. Sanfelice shortly afterwards recovered a similar agent from the lymph node in an ox and called it Saccharomyces lithogenes because there were particular differences between this organism and the first one (Casadevall and Perfect, 1998, Bovers et al., 2008a). A year after the first cryptococcosis case report by Busse and Buschke, Curtis Ferdinand in France, described a “plant parasite” yeast as an etiologic agent of an ulcerating abscess in a young Frenchman with an unremarkable medical history. Based on different morphological features in comparison with the previous described isolates (elongated or oval yeasts) and its affinity for subcutaneous tissue shown in animal models, Curtis labelled this agent Saccharomyces subcutaneous tumefaciens. Despite the absence of epidemiological data, it is currently considered the first report of an autochthonous infection by C. gattii in France (Hagen et al., 2012; Kwon-Chung et al., 2011). These findings demonstrated three cardinal aspects: i) the ability to cause infection in humans and in animals, ii) this, added to the demonstration of Koch’s postulates by Sanfelice and Curtis, showed its pathogenic potential and iii) the fact that it can be recovered from natural sources revealed its saprophytic nature. However, the different denominations received yielded confusion about the true nature of this agent (Casadevall and Perfect, 1998; Bovers et al., 2008a). The genus Cryptococcus was first established in 1833 by Kützing to “accommodate” a new microorganism described as “globose hyaline microscopic organism with undetermined taxonomic position that produces whitish mucoid colonies”. Later, in 1901, Vuillemin argued that the microorganisms isolated by Busse and Sanfelice in 1894 actually belong to this genus. Thereafter, its definition underwent multiple 12 General Introduction proposed amendments until the gender name Cryptococcus Vuillemin and pointed C. neoformans as the type species. Nowadays, the genus includes about 100 pathogenic and non-pathogenic species (Kwon-Chung et al., 2011). 1 One of the main contributions to the current taxonomy of C. neoformans, was the recognition of its sexual stage. In 1975 the first teleomorph, Filobasidiella neoformans, was obtained by mating compatible isolates of serotypes A and D. The second species, Filobasidiella bacillispora was achieved by crosslinking compatible cells of serotypes B and C (Kwon-Chung, 1975). The correlation between the different serotypes and teleomorph states indicated that differences between isolates were not restricted to their antigenic properties. Subsequent studies showed that both species differ in their ecological niches, epidemiology, biochemistry, association with different host immune states, phylogeny and genomic arrangements (Kwon-Chung and Varma, 2006; Kwon- Chung et al., 2011). Studies about this agent and the disease it causes, led to its current classification. What once was considered a “complex species”, is now recognized as a “species complex” (Fonseca et
Load more

Recommended publications
  • Diversity of the Cryptococcus Neoformans-Cryptococcus Gattii Species Complex Marjan Bovers1, Ferry Hagen1 and Teun Boekhout1,2
    S4 Rev Iberoam Micol 2008; 25: S4-S12 Review Diversity of the Cryptococcus neoformans-Cryptococcus gattii species complex Marjan Bovers1, Ferry Hagen1 and Teun Boekhout1,2 1Yeast Research Group, CBS Fungal Diversity Centre, Uppsalalaan 8, 3584 CT Utrecht, The Netherlands; 2Department of Internal Medicine and Infectious Diseases, University Medical Centre Utrecht, The Netherlands Summary More than 110 years of study of the Cryptococcus neoformans and Cryptococcus gattii species complex has resulted in an enormous accumulation of fundamental, applied biological and clinical knowledge. Recent developments in our understanding of the diversity within the species complex are presented, emphasizing the intraspecific complexity, which includes species, microspecies, hybrids, serotypes and genotypes. Each of these may have different roles in disease. An overview of obsolete and current names is presented. Key words Cryptococcus neoformans, Cryptococcus gattii, Yeast, Taxonomy, Pathogen. Diversidad del complejo de especies Cryptococcus neoformans-Cryptococcus gattii Resumen Más de 110 años de estudio sobre el complejo de especies Cryptococcus neoformans y Cryptococcus gattii han dado lugar a un gran acúmulo de conocimiento básico, aplicado y clínico. En este artículo se describen los avances recientes en la comprensión de su diversidad, haciendo énfasis en la complejidad intraespecífica que presenta y que llega a englobar especies, microespecies, híbridos, serotipos y genotipos. Cada uno de estos grupos puede jugar un papel diferente en la enfermedad. Se presenta también una visión global de los nombres obsoletos y actuales de estos taxones. Palabras clave Cryptococcus neoformans, Cryptococcus gattii, Levaduras, Patógeno, Taxonomía. Introduction racteristics of the genus Saccharomyces were not present, he placed these species in the genus Cryptococcus [166].
    [Show full text]
  • Cryptococcus Gattii Outbreak
    The recent Cryptococcus gattii outbreak A deadly pathway… From Trees to Lungs to Brain ryptococcus gattii disease. The route of C has been in the infection is from breathing the news lately, due to a recent airborne organism, which outbreak in the Pacific becomes lodged in the Northwest. This new, more pulmonary tissues. virulent strain is expected to by Jay Hardy, CLS, SM (NRCM) spread further throughout the Symptoms Northwest and Northern California in the coming The pulmonary disease, Jay Hardy is the founder and months. known as cpryptococcosis, president of Hardy Diagnostics. develops slowly. After He began his career in exposure it can take two to microbiology as a Medical Technologist in Santa Barbara, twelve months for symptoms California. to appear, with the usual onset In 1980, he began at six or seven months. manufacturing culture media for the local hospitals. Today, The symptoms include: Hardy Diagnostics is the third largest media manufacturer in the U.S. • Cough that lasts weeks or months To ensure rapid and reliable turn around time, Hardy • Sharp chest pain Figure 1: An India ink stain Diagnostics maintains six • Unexplained shortness of showing the capsule surrounding distribution centers, and breath produces over 3,000 products the C. gattii cells in the yeast form used in clinical and industrial at 1,000X. Photo from Haley/CDC. • Severe headache microbiology laboratories • Confusion throughout the world. The organism is a fungus that • Fever is usually found in the soil • Night sweats www.HardyDiagnostics.com and on trees. It is not spread • Unintended weight loss from human to human or animal to human.
    [Show full text]
  • A Silver Bullet in a Golden Age of Functional Genomics: the Impact of Agrobacterium-Mediated Transformation of Fungi
    Idnurm, A. , Bailey, A. M., Cairns, T., Elliott, C., Foster, G., Ianiri, G., & Jeon, J. (2017). A silver bullet in a golden age of functional genomics: the impact of Agrobacterium-mediated transformation of fungi. Fungal Biology and Biotechnology, 4, [4:6]. https://doi.org/10.1186/s40694- 017-0035-0 Publisher's PDF, also known as Version of record License (if available): CC BY Link to published version (if available): 10.1186/s40694-017-0035-0 Link to publication record in Explore Bristol Research PDF-document This is the final published version of the article (version of record). It first appeared online via BMC at https://fungalbiolbiotech.biomedcentral.com/articles/10.1186/s40694-017-0035-0. Please refer to any applicable terms of use of the publisher. University of Bristol - Explore Bristol Research General rights This document is made available in accordance with publisher policies. Please cite only the published version using the reference above. Full terms of use are available: http://www.bristol.ac.uk/red/research-policy/pure/user-guides/ebr-terms/ Idnurm et al. Fungal Biol Biotechnol (2017) 4:6 DOI 10.1186/s40694-017-0035-0 Fungal Biology and Biotechnology REVIEW Open Access A silver bullet in a golden age of functional genomics: the impact of Agrobacterium‑mediated transformation of fungi Alexander Idnurm1* , Andy M. Bailey2, Timothy C. Cairns3, Candace E. Elliott1, Gary D. Foster2, Giuseppe Ianiri4 and Junhyun Jeon5 Abstract The implementation of Agrobacterium tumefaciens as a transformation tool revolutionized approaches to discover and understand gene functions in a large number of fungal species. A.
    [Show full text]
  • Associations Between Cryptococcus Genotypes, Phenotypes, and Clinical Parameters of Human Disease: a Review
    Journal of Fungi Review Associations between Cryptococcus Genotypes, Phenotypes, and Clinical Parameters of Human Disease: A Review Marhiah C. Montoya 1,2 , Paul M. Magwene 3 and John R. Perfect 1,2,* 1 Division of Infectious Diseases, Department of Medicine, Duke University, Durham, NC 27710, USA; [email protected] 2 Division of Infectious Diseases, Department of Molecular Genetics and Microbiology, Duke University, Durham, NC 27710, USA 3 Department of Biology, Duke University, Durham, NC 27710, USA; [email protected] * Correspondence: [email protected] Abstract: The genus Cryptococcus contains two primary species complexes that are significant op- portunistic human fungal pathogens: C. neoformans and C. gattii. In humans, cryptococcosis can manifest in many ways, but most often results in either pulmonary or central nervous system disease. Patients with cryptococcosis can display a variety of symptoms on a spectrum of severity because of the interaction between yeast and host. The bulk of our knowledge regarding Cryptococcus and the mechanisms of disease stem from in vitro experiments and in vivo animal models that make a fair attempt, but do not recapitulate the conditions inside the human host. To better understand the dynamics of initiation and progression in cryptococcal disease, it is important to study the genetic and phenotypic differences in the context of human infection to identify the human and fungal risk factors that contribute to pathogenesis and poor clinical outcomes. In this review, we summarize the current understanding of the different clinical presentations and health outcomes that are associated with pathogenicity and virulence of cryptococcal strains with respect to specific Citation: Montoya, M.C.; Magwene, P.M.; Perfect, J.R.
    [Show full text]
  • Health and Disease Status in a Threatened Marsupial, the Quokka (Setonix Brachyurus)
    Health and disease status in a threatened marsupial, the quokka (Setonix brachyurus) Pedro Martínez-Pérez Veterinarian (Hons), MVS Conservation Medicine This thesis was submitted in fulfilment of the requirements for the degree of Doctor of Philosophy in Wildlife Veterinary Studies, Murdoch University School of Veterinary and Life Sciences Murdoch University Murdoch, Western Australia January 2016 Declaration I declare that this thesis is my own account of my research and contains as its main content, work which has not been previously submitted for a degree at any tertiary educational institution. _______________________________________________ Pedro A. Martínez-Pérez I Abstract Between 1901 and 1931, there were at least six anecdotal records of disease outbreaks in mainland quokkas (Setonix brachyurus) that were associated with mass. This time period pre-dates the arrival of the red fox (Vulpes vulpes). Despite these outbreaks, little or no research has been carried out to establish health and disease baseline data of the fragmented and scattered, extant populations. Epidemiological data was determined for a range of potential pathogens, and established physiological reference intervals of apparently healthy, wild quokkas on Rottnest Island and mainland locations. There were significant differences between Rottnest Island and mainland quokkas. Rottnest Island animals had haemograms with mark evidence of oxidative injury and bone marrow response consistent with a regenerative normocytic hypochromic anaemia. Except alkaline phosphatase (ALP), all blood chemistry analytes where higher in mainland animals, with particular emphasis on creatine kinase (CK), alanine amino transferase (ALT), aspartate amino transferase (AST) and vitamin E. Some other key findings include a widespread presence of a novel herpesvirus (MaHV-6), the recovery of Cryptococcus neoformans var.
    [Show full text]
  • A Silver Bullet in a Golden Age of Functional Genomics: the Impact of Agrobacterium-Mediated Transformation of Fungi
    Idnurm et al. Fungal Biol Biotechnol (2017) 4:6 DOI 10.1186/s40694-017-0035-0 Fungal Biology and Biotechnology REVIEW Open Access A silver bullet in a golden age of functional genomics: the impact of Agrobacterium‑mediated transformation of fungi Alexander Idnurm1* , Andy M. Bailey2, Timothy C. Cairns3, Candace E. Elliott1, Gary D. Foster2, Giuseppe Ianiri4 and Junhyun Jeon5 Abstract The implementation of Agrobacterium tumefaciens as a transformation tool revolutionized approaches to discover and understand gene functions in a large number of fungal species. A. tumefaciens mediated transformation (AtMT) is one of the most transformative technologies for research on fungi developed in the last 20 years, a development arguably only surpassed by the impact of genomics. AtMT has been widely applied in forward genetics, whereby generation of strain libraries using random T-DNA insertional mutagenesis, combined with phenotypic screening, has enabled the genetic basis of many processes to be elucidated. Alternatively, AtMT has been fundamental for reverse genet- ics, where mutant isolates are generated with targeted gene deletions or disruptions, enabling gene functional roles to be determined. When combined with concomitant advances in genomics, both forward and reverse approaches using AtMT have enabled complex fungal phenotypes to be dissected at the molecular and genetic level. Addition- ally, in several cases AtMT has paved the way for the development of new species to act as models for specifc areas of fungal biology, particularly in plant pathogenic ascomycetes and in a number of basidiomycete species. Despite its impact, the implementation of AtMT has been uneven in the fungi. This review provides insight into the dynamics of expansion of new research tools into a large research community and across multiple organisms.
    [Show full text]
  • Maternal–Fetal Transmission of Cryptococcus Gattii in Harbor Porpoise
    LETTERS Oral Oncul, Yunus Atalay, Maternal–Fetal www.cdc.gov/EID/content/17/2/302- Yalcin Onem, Vedat Turhan, Ali appF.htm). The fi rst stomach chamber Acar, Yavuz Uyar, Transmission of contained two 3.5 cm × 2.5 cm raised, Dilek Y. Caglayik, Sezai Ozkan, Cryptococcus gattii centrally umbilicated ulcers and sev- and Levent Gorenek in Harbor Porpoise eral embedded anisakid nematodes. Author affi liations: Gulhane Military Medi- The uterus was gravid in the right cal Academy Haydarpasa Training Hospi- To the Editor: We report mater- horn with a mid-term fetus. No other tal, Istanbul, Turkey (O. Oncul, Y. Atalay, nal–fetal transmission of Cryptococ- gross lesions were identifi ed. Micro- Y. Onem, V. Turhan, A. Acar, S. Ozkan, L. cus gattii and death in a wild porpoise. scopically, the lung lesions correlated Gorenek); and Refi k Saydam National Pub- Cryptococcus neoformans and C. gat- with granulomatous to pyogranuloma- lic Health Agency, Ankara, Turkey (Y. Uyar, tii are 2 environmental, encapsulated tous infi ltrates, often with a myriad of D.Y. Caglayik) yeasts that cause invasive, potentially yeasts. life-threatening infections in humans The male fetus (length 30 cm, DOI: 10.3201/eid1702.100663 and animals (1). C. neoformans causes weight 2.4 kg), was examined sepa- disease in immunocompromised hosts, rately at a different facility than the References and C. gattii is also pathogenic in im- dam. It appeared grossly normal ex- 1. Tang YW, Li YL, Ye KL, Xu ZY, Ruo munocompetent hosts (2). Since 1999, ternally and was at a gestation of ≈5–6 SL, Fisher-Hoch SP, et al.
    [Show full text]
  • 12 Tremellomycetes and Related Groups
    12 Tremellomycetes and Related Groups 1 1 2 1 MICHAEL WEIß ,ROBERT BAUER ,JOSE´ PAULO SAMPAIO ,FRANZ OBERWINKLER CONTENTS I. Introduction I. Introduction ................................ 00 A. Historical Concepts. ................. 00 Tremellomycetes is a fungal group full of con- B. Modern View . ........................... 00 II. Morphology and Anatomy ................. 00 trasts. It includes jelly fungi with conspicuous A. Basidiocarps . ........................... 00 macroscopic basidiomes, such as some species B. Micromorphology . ................. 00 of Tremella, as well as macroscopically invisible C. Ultrastructure. ........................... 00 inhabitants of other fungal fruiting bodies and III. Life Cycles................................... 00 a plethora of species known so far only as A. Dimorphism . ........................... 00 B. Deviance from Dimorphism . ....... 00 asexual yeasts. Tremellomycetes may be benefi- IV. Ecology ...................................... 00 cial to humans, as exemplified by the produc- A. Mycoparasitism. ................. 00 tion of edible Tremella fruiting bodies whose B. Tremellomycetous Yeasts . ....... 00 production increased in China alone from 100 C. Animal and Human Pathogens . ....... 00 MT in 1998 to more than 250,000 MT in 2007 V. Biotechnological Applications ............. 00 VI. Phylogenetic Relationships ................ 00 (Chang and Wasser 2012), or extremely harm- VII. Taxonomy................................... 00 ful, such as the systemic human pathogen Cryp- A. Taxonomy in Flow
    [Show full text]
  • Cryptococcus Gattii Reporting and Investigation Guideline
    Cryptococcus gattii Signs and • Symptoms depend on affected body system; typically pneumonia (cough, Symptoms shortness of breath, chest pain, fever) and/or meningitis (headache, fever, neck pain, nausea and vomiting, sensitivity to light, altered mental status). May be asymptomatic. • Cryptococcomas in the lungs, skin, brain, or other organs. Incubation Not well-established; average 6-7 months (range 2-13 months), potentially years. Case Clinical criteria: None required classification Confirmed: A case with any of the following from a clinical specimen: isolation of C. gattii; detection of C. gattii-specific nucleic acid; demonstration of C. gattii by immunohistochemistry; MALDI-TOF result specific for C. gattii Differential Coccidioidomycosis, histoplasmosis, blastomycosis, other fungal infections, viral or diagnosis bacterial causes of pneumonia or meningitis Treatment Appropriate antifungal, generally fluconazole for asymptomatic to moderate pulmonary infections or amphotericin B and flucytosine for severe lung infections or CNS infections. Case fatality rate in published literature ranges from 13-33%. Duration Can cause long-term infection; treatment needs to be continued for at least 6 months. Some people may require surgery to remove cryptococcomas. Exposure Inhalation of fungal spores from the environment in endemic regions. No person-to- person or animal-to-person transmission. Laboratory Local Health Jurisdiction (LHJ) and Communicable Disease Epidemiology (CDE) arrange testing testing for individual cases and environmental testing for suspected outbreaks. Isolates should be submitted for speciation. • Washington State Public Health Laboratories can facilitate testing at CDC • Best specimens: Fungal isolate. Testing can be arranged for serum or cerebrospinal fluid (CSF), although tests on these specimens do not differentiate C. gattii from other Cryptococcus species Specimen shipping (Section 4): • Isolates must be submitted on a slant with a screw top.
    [Show full text]
  • Describing Genomic and Epigenomic Traits Underpinning Emerging Fungal Pathogens
    1 Describing genomic and epigenomic traits underpinning 2 emerging fungal pathogens 3 4 Rhys A. Farrer1 and Matthew C. Fisher1 5 6 1Department of Infectious Disease Epidemiology, School of Public Health, Imperial 7 College London, London W2 1PG, UK 8 9 Contents 10 1. Introduction 11 2. Genome Variation Within and Between Populations of Emerging Fungal 12 Pathogens 13 2.1 Assemblies, Alignments and Annotation 14 2.2 Functional Predictions and Gene Family Expansion 15 2.3 Chromosomal Copy Number Variation 16 2.4 Natural Selection 17 2.5 Genomic approaches to detecting reproductive modes, demographic and 18 epidemiological processes in EFPs 19 2.5.1 ‘Know your enemy’ 20 2.5.2 Occurrence of EFPs caused by clonal through to reticulate 21 evolution 22 2.5.3 Mutation rates, molecular clocks and EFPs 23 3. Epigenomic Variation Within and Between Populations of Emerging Fungal 24 Pathogens 25 Acknowledgments 26 References 27 28 1 29 Abstract 30 31 An unprecedented number of pathogenic fungi are emerging and causing disease in 32 animals and plants, putting the resilience of wild and managed ecosystems in 33 jeopardy. While the past decades have seen an increase in the number of 34 pathogenic fungi, they have also seen the birth of new big-data technologies and 35 analytical approaches to tackle these emerging pathogens. We review how the 36 linked fields of genomics and epigenomics are transforming our ability to address the 37 challenge of emerging fungal pathogens. We explore the methodologies and 38 bioinformatic toolkits that currently exist to rapidly analyse the genomes of unknown 39 fungi, then discuss how these data can be used to address key questions that shed 40 light on their epidemiology.
    [Show full text]
  • Cats with Central Nervous System Cryptococcosis
    Acta Scientiae Veterinariae, 2020. 48(Suppl 1): 537. CASE REPORT ISSN 1679-9216 Pub. 537 Cats with Central Nervous System Cryptococcosis Rochana Rodrigues1, Jenifer Severo Beretta2, Andréia Spanamberg3, Mônica Slaviero4, Luiza Presser Ehlers4 & Luciana Sonne4 ABSTRACT Background: Cryptococcosis is a serious fungal infection contracted by humans and animals, and the most common sys- temic mycosis found in cats. This disease is often contracted through inhalation of fungal propagules. The Central Nervous System (CNS) may be infected through local extension (nasal and frontal sinuses) or via hematogenous route. Similarly to CNS bacterial infection, the clinical signs of neurological dysfunction may be attributed to mass effect (gelatinous mass of fungal microorganisms and fungal granuloma formation) or to a more disseminated inflammatory response to invading microorganisms. The objective of this study is to report one case of a patient with cryptococcal granulomas in the central nervous system and one case of a patient with neurological signs associated to a cryptococcosis. Cases: Case 1. A 3-year-old male mixed breed feline was admitted to a veterinary clinic, located in Porto Alegre, RS, Southern Brazil. The patient presented unsourced behavioral changes, vestibular ataxia and dysphagia caused by inability of coordination. The following tests were performed: complete blood count test, biochemical analysis, computed tomog- raphy scan (CT scan), fluid analysis, radiography and toxoplasmosis test. The following medicine were administrated for treatment: fluconazole, dexamethasone, mannitol, phenobarbital and levetiracetam. Fluid therapy was also part of the treatment. Immediately after death, the cat was submitted for necropsy, and a fungal granulomatous meningoencephalo- myelitis was diagnosed. Cryptococcus sp. was identified as the causal agent through pathological findings, fungal culture and PCR analysis.
    [Show full text]
  • Cryptococcus Neoformans and Cryptococcus Gattii Species
    Journal of Fungi Review Cryptococcus neoformans and Cryptococcus gattii Species Complexes in Latin America: A Map of Molecular Types, Genotypic Diversity, and Antifungal Susceptibility as Reported by the Latin American Cryptococcal Study Group Carolina Firacative 1,* , Wieland Meyer 2 and Elizabeth Castañeda 3 1 Studies in Translational Microbiology and Emerging Diseases (MICROS) Research Group, School of Medicine and Health Sciences, Universidad del Rosario, Bogota 111221, Colombia 2 Molecular Mycology Research Laboratory, Centre for Infectious Diseases and Microbiology, Research and Education Network Westmead Hospital, Faculty of Medicine and Health, Sydney Medical School-Westmead Clinical School, Marie Bashir Institute for Infectious Diseases and Biosecurity, Westmead Institute for Medical Research, The University of Sydney, Sydney 2145, Australia; [email protected] 3 Grupo de Microbiología, Instituto Nacional de Salud, Bogota 111321, Colombia; [email protected] * Correspondence: cfi[email protected]; Tel.: +57-1-297-0200 (ext. 3404) Abstract: Cryptococcosis, a potentially fatal mycosis, is caused by members of the Cryptococcus neoformans and Cryptococcus gattii species complexes. In Latin America, cryptococcal meningitis is still an impor- tant health threat with a significant clinical burden. Analysis of publicly available molecular data from 5686 clinical, environmental, and veterinary cryptococcal isolates from member countries of Citation: Firacative, C.; Meyer, W.; the Latin American Cryptococcal Study Group showed that, as worldwide, C. neoformans molecular Castañeda, E. Cryptococcus neoformans type VNI is the most common cause of cryptococcosis (76.01%) in HIV-infected people, followed by and Cryptococcus gattii Species C. gattii molecular type VGII (12.37%), affecting mostly otherwise healthy hosts. These two molecular Complexes in Latin America: A Map types also predominate in the environment (68.60% for VNI and 20.70% for VGII).
    [Show full text]